InsidersTradesSigma
Discover the detailed record of transactions filed by SHOVLIN ROBERT J., Président des Services Cliniques. Officer active across 1 companies, notably Neogenomics INC. Aggregated, 2 reports have been recorded. The latest transaction was disclosed on 25 May 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations
Robert J. Shovlin is the President of Clinical Services at Neogenomics Inc. He leads the company's clinical operations, ensuring efficiency and quality of services. His expertise in biotechnology is crucial for developing innovative health solutions.